Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| Fibroblast | EC50 | 592 nM | Cytoprotective activity against BSO-induced human FRDA primary patient fibroblasts compound pretreated 12 hrs prior to BSO-induction measured after 48 hrs by calcein-AM-based cell viability assay | [PMID: 22137789] |
| Fibroblast | GI50 | 98 μM | Growth inhibition of human FRDA primary patient fibroblasts after 48 hrs by calcein-AM-based cell viability assay | [PMID: 22137789] |
| HepG2 | EC50 | 0.94 μM | Suppression of rotenone-induced ATP depletion in human HepG2 cells incubated for 2 hrs by Celltiter-Glo assay | [PMID: 33180495] |
| HepG2 | IC50 | 64.5 μM | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 hrs by Celltiter-blue assay | [PMID: 33180495] |
| HL-60 | IC50 | > 200 μM | Antiproliferative activity against human mitochondrial gene-knockout HL60 cells after 48 hrs by MTT assay | [PMID: 23432053] |
| HL-60 | IC50 | 36 μM | Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay | [PMID: 23432053] |
| HL-60 | IC50 | 70 μM | Inhibition of tPMET complex in human mitochondrial gene-knockout HL60 cells after 30 mins by WST-1/mPMS reduction assay | [PMID: 23432053] |
| HL-60 | IC50 | 77 μM | Inhibition of tPMET complex in human HL60 cells after 30 mins by WST-1/mPMS reduction assay | [PMID: 23432053] |
| SH-SY5Y | IC50 | 15.9 μM | Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 24 hrs by Celltiter-blue assay | [PMID: 33180495] |
9 records · Scroll to view more